Advanced

Cost/benefit aspects on thromboprophylaxis

Bergqvist, David and Mätzsch, Thomas LU (1993) In Haemostasis 23(Suppl. 1). p.15-19
Abstract
Several studies have shown thromboprophylaxis of any kind to be more cost-effective than no prophylaxis or general diagnostic surveillance and selective treatment. Little has been written on low molecular weight heparins from the cost-effectiveness point of view. This preliminary study shows low molecular weight heparin to be more cost-effective than standard low-dose heparin in most situations of prophylaxis.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Haemostasis
volume
23
issue
Suppl. 1
pages
15 - 19
publisher
Karger
external identifiers
  • pmid:8388349
  • scopus:0027502386
ISSN
0301-0147
language
English
LU publication?
yes
id
02d25bff-d679-4cf5-9ee8-087aee46069e (old id 1107304)
date added to LUP
2008-07-30 15:37:39
date last changed
2017-01-15 04:11:10
@article{02d25bff-d679-4cf5-9ee8-087aee46069e,
  abstract     = {Several studies have shown thromboprophylaxis of any kind to be more cost-effective than no prophylaxis or general diagnostic surveillance and selective treatment. Little has been written on low molecular weight heparins from the cost-effectiveness point of view. This preliminary study shows low molecular weight heparin to be more cost-effective than standard low-dose heparin in most situations of prophylaxis.},
  author       = {Bergqvist, David and Mätzsch, Thomas},
  issn         = {0301-0147},
  language     = {eng},
  number       = {Suppl. 1},
  pages        = {15--19},
  publisher    = {Karger},
  series       = {Haemostasis},
  title        = {Cost/benefit aspects on thromboprophylaxis},
  volume       = {23},
  year         = {1993},
}